Back to History

Fields Changed

Registration

Field Before After
Trial Start Date December 14, 2020 March 01, 2021
Trial End Date January 01, 2022 March 01, 2022
Last Published December 23, 2020 06:43 AM February 21, 2021 05:43 PM
Intervention Start Date December 14, 2020 March 01, 2021
Intervention End Date December 31, 2021 March 01, 2022
Primary Outcomes (End Points) Revenue forecasts, realized revenues, accuracy of revenue forecasts, firm growth, firm profitability, firm growth path, hiring, intended hiring, elasticity of intended and realized hiring in response to revenue changes, elasticity of intended and realized hiring in response to net present value of hiring, level and changes in net present value of hiring, insurance premium on NPV of hiring, certainty equivalent of net present value in hiring, uncertainty in revenue and net present value of hiring, firm investment, hours worked by firm owner or employees, firm productivity, new product development, measures of strategic initiatives from text data, measures of overconfidence (overestimation, overprecision and overplacement) Revenue forecasts, realized revenues, accuracy of revenue forecasts, firm growth, firm profitability, firm growth path, hiring, intended hiring, elasticity of intended and realized hiring in response to revenue changes, firm productivity, new product development, measures of strategic initiatives from text data, measures of overconfidence (overestimation, overprecision and overplacement), measures of misattribution bias, measures of digital technology adoption, measures of different types of perceived risk
Planned Number of Clusters 400 1000
Planned Number of Observations 400 firms, 6 observations per firm, so 2,400 observations without attrition. However, we will replenish firms to offset sample attrition. 1000 firms, 12 observations per firm. However, we will replenish firms to offset sample attrition. We will run the treatments in the replenished firms.
Sample size (or number of clusters) by treatment arms 200 firms in treatment 1, 200 firms in treatment 2 333 in control group, 333 firms in treatment 1, 333 firms in treatment 2
Back to top